GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 04/15 11:35:28 am
1348.4GBX +4.56%

Turn to zoom
Prev.1289.6000
Open1285.6000
High1388.4000
Low1269.0890
Volume21 234 212
Latest news
8h ago
9h ago
9h ago
10h ago
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance1 3671 4681 414
Spread/Res.-1,4%-8,1%-4,6%
Spread/Supp.5,5%13%13%
Support1 2781 1911 191
Financials
Sales 2021 33 651 M 46 380 M 46 380 M
Net income 2021 3 807 M 5 247 M 5 247 M
Net Debt 2021 21 383 M 29 471 M 29 471 M
P/E ratio 2021 17,4x
Yield 2021 5,90%
Capitalization 67 183 M 92 611 M 92 596 M
EV / Sales 2021 2,63x
EV / Sales 2022 2,47x
Nbr of Employees 94 066
Free-Float 92,5%
Company
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (50%): intended for respiratory diseases (64.9% of net sales), HIV infection (28.6%), immune system disorders (4.3%) ) and cancer (2.2%);
- OTC and...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-04-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus HOLD
Number of Analysts 27
Average target price 1 516,25 GBX
Last Close Price 1 348,40 GBX
Spread / Highest target 52,0%
Spread / Average Target 12,4%
Spread / Lowest Target -28,5%